Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.645, 2012-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Second-line drug therapy for osteoarthritis
Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. :
Gefitinib promising as second-line therapy for oesophageal cancer
Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. :
Second-line quadruple therapy effective for H. pylori eradication
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :